NCT04747912 2026-03-30Study of Chemotherapy-Free Induction Regimen for Ph+ Acute Lymphoblastic Leukemia With Inotuzumab Ozogamicin (InO)University of ChicagoPhase 2 Suspended25 enrolled
NCT05645718 2025-10-07Study of Pedi-cRIB: Mini-Hyper-CVD With Condensed Rituximab, Inotuzumab Ozogamicin and Blinatumomab (cRIB) for Relapsed Therapy for Pediatric With B-Cell Lineage Acute Lymphocytic LeukemiaM.D. Anderson Cancer CenterPhase 2 Recruiting27 enrolled